Page 338 - Binder2
P. 338
This model introduces something almost foreign to
traditional pharma:
Built-in redundancy—with minimal cost.
How It Works
With proper process controls and digital traceability—
tracking plant lineage, gene construct, growth parameters,
and batch harvesting—multiple grow sites can produce
the same therapeutic product simultaneously.
This model allows for:
336